Last updated: December 10, 2020
Your Privacy; Consent
How We Collect, Use and Share Your Information
In the course of populating our clinical trials with suitable patients who meet the various eligibility criteria of a given study, we may ask specific, personal, medical questions relating to an individual’s cancer diagnosis. In doing so, we use a system for compiling information which undertakes to be compliant with the United States' Health Insurance Portability and Accountability Act of 1996 (HIPAA). We may also seek, with your explicit consent, personal contact information in order to follow up with eligible clinical trial candidates to ask additional qualifying questions and to coordinate subsequent steps towards participation in the trial, if applicable. Such personal health and contact information may also be offered to us without our solicitation, including by means of email or by contacting us through the Site.
You may voluntarily sign up to our mailing list to be notified about future trials by clicking on the button “Subscribe to our Newsletter” on https://www.alphatau.com/news. The subscription is operated by a marketing platform which undertakes to be GDPR compliant. For this service, upon receiving your explicit consent, we will obtain your e-mail address, your first name and your last name (not required), which we use only for the purpose of sending you the information you requested. You may of course be able to unsubscribe from such mailing list at any time, either by clicking on the unsubscribe link included in all newsletters, or by contacting us at https://www.alphatau.com/contact.
All data collected by Alpha Tau is processed internally for the purpose of determining preliminary eligibility in clinical trials or for communicating with people who express interest in receiving updates about Alpha Tau. In the event a user might participate in a clinical trial, then we will share the user’s personal health information which was provided in response to our questionnaires only with the relevant medical institutions which are conducting the clinical trials. We may also share such data with a clinical research organization (CRO) which provides support in conducting the trial, but we will not make any use of such user’s data during the course of a trial, in order to maintain the user’s privacy, and in order to uphold the international standards of Good Clinical Practice. When we do share information with these healthcare professionals and CROs, they may provide users with the information leaflet containing an informed consent form which sets out the required information about the clinical trial and a separate privacy notice detailing how they will use their information. Please note that Alpha TAU does not control who will ultimately participate in a clinical trial. Additionally, we may share your data only where necessary for us to comply with any legal obligations to which we are subject, to exercise our legal rights, or to protect ourselves or any other person when reasonably required. Alpha Tau does not sell, trade or rent your personal information to any third party.
How We Store and Secure Your Data
Information regarding users will be maintained, processed and stored by Alpha Tau and our authorized affiliates in secured cloud storage in Israel and the United States, as necessary, provided by third-party service providers which currently represent themselves as maintaining high security credentials. Our servers contain firewalls and anti-virus technology that reflects industry standards in order to secure your data against loss, unauthorized access, or improper use. Likewise, we employ Secure Sockets Layer (SSL) encryption technology to protect your personal data sent to us through the Site.
However, we do not and cannot guarantee that unauthorized access will never occur. No Internet or Wi-Fi transmission can ever be 100% guaranteed as secure, and so we encourage you to take care when disclosing personal data online, and to use readily available tools, such as Internet firewalls, anti-virus and anti-spyware software and similar technologies to protect yourself online.
We intend to keep a record of our communication with you for legal compliance and for legitimate internal purposes on our secured servers. Please be further advised that we may continue to store your information regardless of: (a) whether you were eligible or ineligible for a given clinical trial, (b) whether or not you entered a given clinical trial; (c) the results of a given clinical trial, or (d) whether a clinical trial was discontinued for any reason. In any event, we shall only store your information when so justified on a lawful basis. More specifically, we may retain your contact and personal information for a reasonable period and may contact you in the event of future clinical trial or treatment opportunities which may be relevant based upon your responses to our questionnaires. We will of course delete all such correspondences and cease all communications, where legally and practically feasible, upon your written request, by contacting us at the address provided below. We may also continue to store anonymized, aggregated data for analytic purposes, and will not share such data except with specific vendors who obligate themselves to maintain the same standards of data privacy as more detailed below.
How We Monitor Your Use of the Site
Alpha Tau uses “Cookies” which are small pieces of information that are stored by your browser on your computer’s hard drive, in order to provide features designed to enhance the service we provide. Our cookies do not contain any personally identifying information. Most web browsers automatically accept cookies, but you can usually change your browser to remove them. Even without a cookie, you can still use most of the features on the Site, including signing up for studies or our newsletter.